The Unmet Need:
Each year in the U.S., over 600,000 people die due to cancer. The majority of these deaths are due to the unresolved problem of drug resistance. Most fatal cancers are drug resistant.
Our Solution
Based on our laboratory data, BRG drugs work in human cancer types that have few to no effective treatments, and they alter tumor cell resistance to selected anticancer agents so that all to nearly all tumor cells are killed after just one exposure to the two anticancer agents together.